Allianz Asset Management Gmb H Harmony Biosciences Holdings, Inc. Transaction History
Allianz Asset Management Gmb H
- $70.3 Billion
- Q1 2025
A detailed history of Allianz Asset Management Gmb H transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 220,704 shares of HRMY stock, worth $7.73 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
220,704
Previous 12,200
1709.05%
Holding current value
$7.73 Million
Previous $419,000
1648.21%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HRMY
# of Institutions
278Shares Held
44.8MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$232 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$204 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$165 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$55.3 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$45.1 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.07B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...